tirzepatide 中国 市值近6000亿美元!礼来Zepbound(tirzepatide)新适应症获美国FDA批准医药新闻-ByDrug-一站式医药资源共享中心-医药魔方 入局百亿减肥药市场,礼来的Tirzepatide在中国III期临床获得成功|胰岛素|靶点|药物|临床试验|糖尿病_手机新浪网
Pay in 4 interest-free payments of $5.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























